The present results provide evidence that the PCOS uterus suffers from tissue and oxidative alterations associated with MG-AGE accumulation and that LC, ALC and PLC administration alleviates PCOS uterine tissue alterations and molecular damage with differential effects. This evidence concerns the gene HSPG2 and polycystic ovary syndrome.